261 related articles for article (PubMed ID: 26730411)
1. Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP.
Maszewska A; Wójcik E; Ciurzyńska A; Wojtasik A; Piątkowska I; Dastych J; Różalski A
Acta Biochim Pol; 2016; 63(2):303-10. PubMed ID: 26730411
[TBL] [Abstract][Full Text] [Related]
2. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
[TBL] [Abstract][Full Text] [Related]
4. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.
Gomaa S; Serry F; Abdellatif H; Abbas H
Arch Virol; 2019 Sep; 164(9):2265-2275. PubMed ID: 31197549
[TBL] [Abstract][Full Text] [Related]
5. A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
Mirzaei A; Wagemans J; Nasr Esfahani B; Lavigne R; Moghim S
Microbiol Spectr; 2022 Oct; 10(5):e0209222. PubMed ID: 36194151
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.
Lehman SM; Donlan RM
Antimicrob Agents Chemother; 2015 Feb; 59(2):1127-37. PubMed ID: 25487795
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.
Esmael A; Abo-Elmaaty SA; Khafaga EM; Abdelrahman S; Hassan MG
Arch Virol; 2021 Dec; 166(12):3311-3322. PubMed ID: 34559314
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a group of new Proteus bacteriophages.
Morozova V; Kozlova Y; Shedko E; Babkin I; Kurilshikov A; Bokovaya O; Bardashova A; Yunusova A; Tikunov A; Tupikin A; Ushakova T; Ryabchikova E; Tikunova N
Arch Virol; 2018 Aug; 163(8):2189-2197. PubMed ID: 29721709
[TBL] [Abstract][Full Text] [Related]
9. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
10. Isolation and Purification of Proteus mirabilis Bacteriophage.
Maszewska A; Różalski A
Methods Mol Biol; 2019; 2021():231-240. PubMed ID: 31309509
[TBL] [Abstract][Full Text] [Related]
11. Indwelling Urinary Catheter Model of Proteus mirabilis Infection.
Smith SN; Armbruster CE
Methods Mol Biol; 2019; 2021():187-200. PubMed ID: 31309506
[TBL] [Abstract][Full Text] [Related]
12. Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.
Melo LD; Veiga P; Cerca N; Kropinski AM; Almeida C; Azeredo J; Sillankorva S
Front Microbiol; 2016; 7():1024. PubMed ID: 27446059
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.
Yazdi M; Bouzari M; Ghaemi EA
J Mol Microbiol Biotechnol; 2018; 28(1):37-46. PubMed ID: 29617701
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage Can Prevent Encrustation and Blockage of Urinary Catheters by Proteus mirabilis.
Nzakizwanayo J; Hanin A; Alves DR; McCutcheon B; Dedi C; Salvage J; Knox K; Stewart B; Metcalfe A; Clark J; Gilmore BF; Gahan CG; Jenkins AT; Jones BV
Antimicrob Agents Chemother; 2015 Dec; 60(3):1530-6. PubMed ID: 26711744
[TBL] [Abstract][Full Text] [Related]
15. Characterization, genome analysis and antibiofilm efficacy of lytic Proteus phages RP6 and RP7 isolated from university hospital sewage.
Ali S; Karaynir A; Salih H; Öncü S; Bozdoğan B
Virus Res; 2023 Mar; 326():199049. PubMed ID: 36717023
[TBL] [Abstract][Full Text] [Related]
16. Isolation and Characterization of Lytic
Aaron J; van Zyl LJ; Dicks LMT
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746779
[No Abstract] [Full Text] [Related]
17. Characterization of bacteriophages with a lytic effect on various Salmonella serotypes and Escherichia coli O157:H7.
López-Cuevas O; Castro-Del Campo N; León-Félix J; González-Robles A; Chaidez C
Can J Microbiol; 2011 Dec; 57(12):1042-51. PubMed ID: 22145760
[TBL] [Abstract][Full Text] [Related]
18. Isolation and Characterization of the
da Silva JD; Bens L; Santos AJDC; Lavigne R; Soares J; Melo LDR; Vallino M; Dias RS; Drulis-Kawa Z; de Paula SO; Wagemans J
Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37763984
[No Abstract] [Full Text] [Related]
19. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli.
Carson L; Gorman SP; Gilmore BF
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):447-55. PubMed ID: 20528927
[TBL] [Abstract][Full Text] [Related]
20. Isolation, biological and whole genome characteristics of a Proteus mirabilis bacteriophage strain.
Hao X; Cen X; He M; Wen Y; Zhang H
BMC Microbiol; 2023 Aug; 23(1):215. PubMed ID: 37553593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
